Skip to main content

Inovio's Kim out as CEO, company shifts focus from Covid-19 vaccine to booster

The Plymouth Meeting company encountered a series of setbacks in its ultimately unsuccessful efforts to get a Covid-19 vaccine approved.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.